Neovasc

Neovasc

Neovasc

We develop medical devices that treat cardiovascular conditions, including angina and valve disease. Register for updates via email on our site
Raised
$75M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$75,000,000
Post-IPO equity - 2016
Boston Scientific
Team Size
1–10
Employees
$75,000,000 Post-IPO equity
Business In Vancouver

Neovasc closes US$75 million pact with Boston Scientific

Xconomy

Boston Scientific to Buy Neovasc Heart Valve Assets in $75M Deal

Health